Valneva SE (VALN) Change in Acquisitions & Divestments (2024 - 2026)

Valneva SE (VALN) posted Change in Acquisitions & Divestments of $511615.8 for Q1 2026, up 100.52% sequentially from -$98.7 million in Q1 2024.

Analysis

Valneva SE (VALN) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends

Valneva SE has reported Change in Acquisitions & Divestments for 2 years, with the latest figure at $511615.8 in Q1 2026.

Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $511615.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $511615.8 (changed N/A YoY) and the FY2024 annual result came in at -$98.3 million, changed N/A from the prior year.
Change in Acquisitions & Divestments grew to $511615.8 in Q1 2026 per VALN's latest filing, from -$98.7 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $511615.8 in Q1 2026 and troughed at -$98.7 million in Q1 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	Valneva SE	578.54 Mn	437.28 Mn	1.86 Mn

Historic Data

Download Data